The global Carbapenem API market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Carbapenem API is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The China market for Carbapenem API is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The Europe market for Carbapenem API is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global key manufacturers of Carbapenem API include ACS Dobfar, Savior Lifetec Corporation, Sumitomo Chemical Company, Shenzhen Haibin Pharmaceutical, Zhuhai United Laboratories, Zhejiang Hisun Pharmaceutical, Zhejiang Jiuzhou Pharmaceutical, Sun Pharma and Kopran, etc. In 2022, the global top five players had a share approximately % in terms of revenue.
In terms of production side, this report researches the Carbapenem API production, growth rate, market share by manufacturers and by region (region level and country level), from 2018 to 2023, and forecast to 2029.
In terms of consumption side, this report focuses on the sales of Carbapenem API by region (region level and country level), by company, by Type and by Application. from 2018 to 2023 and forecast to 2029.
Report Includes:
This report presents an overview of global market for Carbapenem API, capacity, output, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.
This report researches the key producers of Carbapenem API, also provides the consumption of main regions and countries. Highlights of the upcoming market potential for Carbapenem API, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Carbapenem API sales, revenue, market share and industry ranking of main manufacturers, data from 2018 to 2023. Identification of the major stakeholders in the global Carbapenem API market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2018 to 2029. Evaluation and forecast the market size for Carbapenem API sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including ACS Dobfar, Savior Lifetec Corporation, Sumitomo Chemical Company, Shenzhen Haibin Pharmaceutical, Zhuhai United Laboratories, Zhejiang Hisun Pharmaceutical, Zhejiang Jiuzhou Pharmaceutical, Sun Pharma and Kopran, etc.
By Company
ACS Dobfar
Savior Lifetec Corporation
Sumitomo Chemical Company
Shenzhen Haibin Pharmaceutical
Zhuhai United Laboratories
Zhejiang Hisun Pharmaceutical
Zhejiang Jiuzhou Pharmaceutical
Sun Pharma
Kopran
Hainan Haiyao
Zhejiang Hisoar
Kaliberr Labs
Jeil Pharmaceutical
Qilu Pharmaceutical
Segment by Type
Ertapenem API
Imipenem API
Meropenem API
Others
Segment by Application
Intravenous Injection
Intramuscular Injection
Production by Region
North America
Europe
China
Japan
Sales by Region
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Middle East, Africa, Latin America
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Carbapenem API production/output of global and key producers (regions/countries). It provides a quantitative analysis of the production and development potential of each producer in the next six years.
Chapter 3: Sales (consumption), revenue of Carbapenem API in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Carbapenem API manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America (US & Canada) by type, by application and by country, sales and revenue for each segment.
Chapter 8: Europe by type, by application and by country, sales and revenue for each segment.
Chapter 9: China by type and by application sales and revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, sales and revenue for each segment.
Chapter 11: Middle East, Africa, Latin America by type, by application and by country, sales and revenue for each segment.
Chapter 12: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Carbapenem API sales, revenue, price, gross margin, and recent development, etc.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 15: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Study Coverage
1.1 Carbapenem API Product Introduction
1.2 Market by Type
1.2.1 Global Carbapenem API Market Size by Type, 2018 VS 2022 VS 2029
1.2.2 Ertapenem API
1.2.3 Imipenem API
1.2.4 Meropenem API
1.2.5 Others
1.3 Market by Application
1.3.1 Global Carbapenem API Market Size by Application, 2018 VS 2022 VS 2029
1.3.2 Intravenous Injection
1.3.3 Intramuscular Injection
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Carbapenem API Production
2.1 Global Carbapenem API Production Capacity (2018-2029)
2.2 Global Carbapenem API Production by Region: 2018 VS 2022 VS 2029
2.3 Global Carbapenem API Production by Region
2.3.1 Global Carbapenem API Historic Production by Region (2018-2023)
2.3.2 Global Carbapenem API Forecasted Production by Region (2024-2029)
2.3.3 Global Carbapenem API Production Market Share by Region (2018-2029)
2.4 North America
2.5 Europe
2.6 China
2.7 Japan
3 Executive Summary
3.1 Global Carbapenem API Revenue Estimates and Forecasts 2018-2029
3.2 Global Carbapenem API Revenue by Region
3.2.1 Global Carbapenem API Revenue by Region: 2018 VS 2022 VS 2029
3.2.2 Global Carbapenem API Revenue by Region (2018-2023)
3.2.3 Global Carbapenem API Revenue by Region (2024-2029)
3.2.4 Global Carbapenem API Revenue Market Share by Region (2018-2029)
3.3 Global Carbapenem API Sales Estimates and Forecasts 2018-2029
3.4 Global Carbapenem API Sales by Region
3.4.1 Global Carbapenem API Sales by Region: 2018 VS 2022 VS 2029
3.4.2 Global Carbapenem API Sales by Region (2018-2023)
3.4.3 Global Carbapenem API Sales by Region (2024-2029)
3.4.4 Global Carbapenem API Sales Market Share by Region (2018-2029)
3.5 US & Canada
3.6 Europe
3.7 China
3.8 Asia (excluding China)
3.9 Middle East, Africa and Latin America
4 Competition by Manufactures
4.1 Global Carbapenem API Sales by Manufacturers
4.1.1 Global Carbapenem API Sales by Manufacturers (2018-2023)
4.1.2 Global Carbapenem API Sales Market Share by Manufacturers (2018-2023)
4.1.3 Global Top 10 and Top 5 Largest Manufacturers of Carbapenem API in 2022
4.2 Global Carbapenem API Revenue by Manufacturers
4.2.1 Global Carbapenem API Revenue by Manufacturers (2018-2023)
4.2.2 Global Carbapenem API Revenue Market Share by Manufacturers (2018-2023)
4.2.3 Global Top 10 and Top 5 Companies by Carbapenem API Revenue in 2022
4.3 Global Carbapenem API Sales Price by Manufacturers
4.4 Global Key Players of Carbapenem API, Industry Ranking, 2021 VS 2022 VS 2023
4.5 Analysis of Competitive Landscape
4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
4.5.2 Global Carbapenem API Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.6 Global Key Manufacturers of Carbapenem API, Manufacturing Base Distribution and Headquarters
4.7 Global Key Manufacturers of Carbapenem API, Product Offered and Application
4.8 Global Key Manufacturers of Carbapenem API, Date of Enter into This Industry
4.9 Mergers & Acquisitions, Expansion Plans
5 Market Size by Type
5.1 Global Carbapenem API Sales by Type
5.1.1 Global Carbapenem API Historical Sales by Type (2018-2023)
5.1.2 Global Carbapenem API Forecasted Sales by Type (2024-2029)
5.1.3 Global Carbapenem API Sales Market Share by Type (2018-2029)
5.2 Global Carbapenem API Revenue by Type
5.2.1 Global Carbapenem API Historical Revenue by Type (2018-2023)
5.2.2 Global Carbapenem API Forecasted Revenue by Type (2024-2029)
5.2.3 Global Carbapenem API Revenue Market Share by Type (2018-2029)
5.3 Global Carbapenem API Price by Type
5.3.1 Global Carbapenem API Price by Type (2018-2023)
5.3.2 Global Carbapenem API Price Forecast by Type (2024-2029)
6 Market Size by Application
6.1 Global Carbapenem API Sales by Application
6.1.1 Global Carbapenem API Historical Sales by Application (2018-2023)
6.1.2 Global Carbapenem API Forecasted Sales by Application (2024-2029)
6.1.3 Global Carbapenem API Sales Market Share by Application (2018-2029)
6.2 Global Carbapenem API Revenue by Application
6.2.1 Global Carbapenem API Historical Revenue by Application (2018-2023)
6.2.2 Global Carbapenem API Forecasted Revenue by Application (2024-2029)
6.2.3 Global Carbapenem API Revenue Market Share by Application (2018-2029)
6.3 Global Carbapenem API Price by Application
6.3.1 Global Carbapenem API Price by Application (2018-2023)
6.3.2 Global Carbapenem API Price Forecast by Application (2024-2029)
7 US & Canada
7.1 US & Canada Carbapenem API Market Size by Type
7.1.1 US & Canada Carbapenem API Sales by Type (2018-2029)
7.1.2 US & Canada Carbapenem API Revenue by Type (2018-2029)
7.2 US & Canada Carbapenem API Market Size by Application
7.2.1 US & Canada Carbapenem API Sales by Application (2018-2029)
7.2.2 US & Canada Carbapenem API Revenue by Application (2018-2029)
7.3 US & Canada Carbapenem API Sales by Country
7.3.1 US & Canada Carbapenem API Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 US & Canada Carbapenem API Sales by Country (2018-2029)
7.3.3 US & Canada Carbapenem API Revenue by Country (2018-2029)
7.3.4 United States
7.3.5 Canada
8 Europe
8.1 Europe Carbapenem API Market Size by Type
8.1.1 Europe Carbapenem API Sales by Type (2018-2029)
8.1.2 Europe Carbapenem API Revenue by Type (2018-2029)
8.2 Europe Carbapenem API Market Size by Application
8.2.1 Europe Carbapenem API Sales by Application (2018-2029)
8.2.2 Europe Carbapenem API Revenue by Application (2018-2029)
8.3 Europe Carbapenem API Sales by Country
8.3.1 Europe Carbapenem API Revenue by Country: 2018 VS 2022 VS 2029
8.3.2 Europe Carbapenem API Sales by Country (2018-2029)
8.3.3 Europe Carbapenem API Revenue by Country (2018-2029)
8.3.4 Germany
8.3.5 France
8.3.6 U.K.
8.3.7 Italy
8.3.8 Russia
9 China
9.1 China Carbapenem API Market Size by Type
9.1.1 China Carbapenem API Sales by Type (2018-2029)
9.1.2 China Carbapenem API Revenue by Type (2018-2029)
9.2 China Carbapenem API Market Size by Application
9.2.1 China Carbapenem API Sales by Application (2018-2029)
9.2.2 China Carbapenem API Revenue by Application (2018-2029)
10 Asia (excluding China)
10.1 Asia Carbapenem API Market Size by Type
10.1.1 Asia Carbapenem API Sales by Type (2018-2029)
10.1.2 Asia Carbapenem API Revenue by Type (2018-2029)
10.2 Asia Carbapenem API Market Size by Application
10.2.1 Asia Carbapenem API Sales by Application (2018-2029)
10.2.2 Asia Carbapenem API Revenue by Application (2018-2029)
10.3 Asia Carbapenem API Sales by Region
10.3.1 Asia Carbapenem API Revenue by Region: 2018 VS 2022 VS 2029
10.3.2 Asia Carbapenem API Revenue by Region (2018-2029)
10.3.3 Asia Carbapenem API Sales by Region (2018-2029)
10.3.4 Japan
10.3.5 South Korea
10.3.6 China Taiwan
10.3.7 Southeast Asia
10.3.8 India
11 Middle East, Africa and Latin America
11.1 Middle East, Africa and Latin America Carbapenem API Market Size by Type
11.1.1 Middle East, Africa and Latin America Carbapenem API Sales by Type (2018-2029)
11.1.2 Middle East, Africa and Latin America Carbapenem API Revenue by Type (2018-2029)
11.2 Middle East, Africa and Latin America Carbapenem API Market Size by Application
11.2.1 Middle East, Africa and Latin America Carbapenem API Sales by Application (2018-2029)
11.2.2 Middle East, Africa and Latin America Carbapenem API Revenue by Application (2018-2029)
11.3 Middle East, Africa and Latin America Carbapenem API Sales by Country
11.3.1 Middle East, Africa and Latin America Carbapenem API Revenue by Country: 2018 VS 2022 VS 2029
11.3.2 Middle East, Africa and Latin America Carbapenem API Revenue by Country (2018-2029)
11.3.3 Middle East, Africa and Latin America Carbapenem API Sales by Country (2018-2029)
11.3.4 Brazil
11.3.5 Mexico
11.3.6 Turkey
11.3.7 Israel
11.3.8 GCC Countries
12 Corporate Profiles
12.1 ACS Dobfar
12.1.1 ACS Dobfar Company Information
12.1.2 ACS Dobfar Overview
12.1.3 ACS Dobfar Carbapenem API Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
12.1.4 ACS Dobfar Carbapenem API Product Model Numbers, Pictures, Descriptions and Specifications
12.1.5 ACS Dobfar Recent Developments
12.2 Savior Lifetec Corporation
12.2.1 Savior Lifetec Corporation Company Information
12.2.2 Savior Lifetec Corporation Overview
12.2.3 Savior Lifetec Corporation Carbapenem API Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
12.2.4 Savior Lifetec Corporation Carbapenem API Product Model Numbers, Pictures, Descriptions and Specifications
12.2.5 Savior Lifetec Corporation Recent Developments
12.3 Sumitomo Chemical Company
12.3.1 Sumitomo Chemical Company Company Information
12.3.2 Sumitomo Chemical Company Overview
12.3.3 Sumitomo Chemical Company Carbapenem API Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
12.3.4 Sumitomo Chemical Company Carbapenem API Product Model Numbers, Pictures, Descriptions and Specifications
12.3.5 Sumitomo Chemical Company Recent Developments
12.4 Shenzhen Haibin Pharmaceutical
12.4.1 Shenzhen Haibin Pharmaceutical Company Information
12.4.2 Shenzhen Haibin Pharmaceutical Overview
12.4.3 Shenzhen Haibin Pharmaceutical Carbapenem API Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
12.4.4 Shenzhen Haibin Pharmaceutical Carbapenem API Product Model Numbers, Pictures, Descriptions and Specifications
12.4.5 Shenzhen Haibin Pharmaceutical Recent Developments
12.5 Zhuhai United Laboratories
12.5.1 Zhuhai United Laboratories Company Information
12.5.2 Zhuhai United Laboratories Overview
12.5.3 Zhuhai United Laboratories Carbapenem API Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
12.5.4 Zhuhai United Laboratories Carbapenem API Product Model Numbers, Pictures, Descriptions and Specifications
12.5.5 Zhuhai United Laboratories Recent Developments
12.6 Zhejiang Hisun Pharmaceutical
12.6.1 Zhejiang Hisun Pharmaceutical Company Information
12.6.2 Zhejiang Hisun Pharmaceutical Overview
12.6.3 Zhejiang Hisun Pharmaceutical Carbapenem API Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
12.6.4 Zhejiang Hisun Pharmaceutical Carbapenem API Product Model Numbers, Pictures, Descriptions and Specifications
12.6.5 Zhejiang Hisun Pharmaceutical Recent Developments
12.7 Zhejiang Jiuzhou Pharmaceutical
12.7.1 Zhejiang Jiuzhou Pharmaceutical Company Information
12.7.2 Zhejiang Jiuzhou Pharmaceutical Overview
12.7.3 Zhejiang Jiuzhou Pharmaceutical Carbapenem API Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
12.7.4 Zhejiang Jiuzhou Pharmaceutical Carbapenem API Product Model Numbers, Pictures, Descriptions and Specifications
12.7.5 Zhejiang Jiuzhou Pharmaceutical Recent Developments
12.8 Sun Pharma
12.8.1 Sun Pharma Company Information
12.8.2 Sun Pharma Overview
12.8.3 Sun Pharma Carbapenem API Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
12.8.4 Sun Pharma Carbapenem API Product Model Numbers, Pictures, Descriptions and Specifications
12.8.5 Sun Pharma Recent Developments
12.9 Kopran
12.9.1 Kopran Company Information
12.9.2 Kopran Overview
12.9.3 Kopran Carbapenem API Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
12.9.4 Kopran Carbapenem API Product Model Numbers, Pictures, Descriptions and Specifications
12.9.5 Kopran Recent Developments
12.10 Hainan Haiyao
12.10.1 Hainan Haiyao Company Information
12.10.2 Hainan Haiyao Overview
12.10.3 Hainan Haiyao Carbapenem API Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
12.10.4 Hainan Haiyao Carbapenem API Product Model Numbers, Pictures, Descriptions and Specifications
12.10.5 Hainan Haiyao Recent Developments
12.11 Zhejiang Hisoar
12.11.1 Zhejiang Hisoar Company Information
12.11.2 Zhejiang Hisoar Overview
12.11.3 Zhejiang Hisoar Carbapenem API Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
12.11.4 Zhejiang Hisoar Carbapenem API Product Model Numbers, Pictures, Descriptions and Specifications
12.11.5 Zhejiang Hisoar Recent Developments
12.12 Kaliberr Labs
12.12.1 Kaliberr Labs Company Information
12.12.2 Kaliberr Labs Overview
12.12.3 Kaliberr Labs Carbapenem API Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
12.12.4 Kaliberr Labs Carbapenem API Product Model Numbers, Pictures, Descriptions and Specifications
12.12.5 Kaliberr Labs Recent Developments
12.13 Jeil Pharmaceutical
12.13.1 Jeil Pharmaceutical Company Information
12.13.2 Jeil Pharmaceutical Overview
12.13.3 Jeil Pharmaceutical Carbapenem API Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
12.13.4 Jeil Pharmaceutical Carbapenem API Product Model Numbers, Pictures, Descriptions and Specifications
12.13.5 Jeil Pharmaceutical Recent Developments
12.14 Qilu Pharmaceutical
12.14.1 Qilu Pharmaceutical Company Information
12.14.2 Qilu Pharmaceutical Overview
12.14.3 Qilu Pharmaceutical Carbapenem API Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
12.14.4 Qilu Pharmaceutical Carbapenem API Product Model Numbers, Pictures, Descriptions and Specifications
12.14.5 Qilu Pharmaceutical Recent Developments
13 Industry Chain and Sales Channels Analysis
13.1 Carbapenem API Industry Chain Analysis
13.2 Carbapenem API Key Raw Materials
13.2.1 Key Raw Materials
13.2.2 Raw Materials Key Suppliers
13.3 Carbapenem API Production Mode & Process
13.4 Carbapenem API Sales and Marketing
13.4.1 Carbapenem API Sales Channels
13.4.2 Carbapenem API Distributors
13.5 Carbapenem API Customers
14 Carbapenem API Market Dynamics
14.1 Carbapenem API Industry Trends
14.2 Carbapenem API Market Drivers
14.3 Carbapenem API Market Challenges
14.4 Carbapenem API Market Restraints
15 Key Finding in The Global Carbapenem API Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
ACS Dobfar
Savior Lifetec Corporation
Sumitomo Chemical Company
Shenzhen Haibin Pharmaceutical
Zhuhai United Laboratories
Zhejiang Hisun Pharmaceutical
Zhejiang Jiuzhou Pharmaceutical
Sun Pharma
Kopran
Hainan Haiyao
Zhejiang Hisoar
Kaliberr Labs
Jeil Pharmaceutical
Qilu Pharmaceutical
听
听
*If Applicable.
